Eli Lilly and Company - Diluted Average Shares

Eli Lilly and Company's Fiscal Year is From January To December - All Figures are in Billions.

The item "Diluted-Average-Shares" stands at 3.60 Billion for the trailing twelve months (TTM) period ending 09/30/2025, the lowest value at least since 03/31/2012, the period currently displayed.

Eli Lilly and Company's third quarter result of 0.8988 Billion for the item "Diluted Average Shares" represents a decrease of -0.11 percent compared to it's second quarter result.

Also, Eli Lilly and Company's third quarter result of 0.8988 Billion for the item "Diluted Average Shares" represents a decrease of -0.69 percent compared to it's third quarter result of last year.

Looking again at the trailing twelve months series (TTM), Eli Lilly and Company's third quarter result of 3.60 Billion for the item "Diluted Average Shares" represents a decrease of -0.17 percent compared to it's second quarter result.


Regarding the One-Year-Change of the series, the current value constitutes a decrease of -0.4043 percent compared to the value the year prior.
The 1 year change in percent is -0.4043.
The 3 year change in percent is -2.93.
The 5 year change in percent is -5.88.
The 10 year change in percent is -18.81.

The Serie's long term average value is 4.11 Billion. It's latest available value, on 09/30/2025, is 12.31 percent lower, compared to it's long term average value.
The Serie's change in percent from it's minimum value, on 09/30/2025, to it's latest available value, on 09/30/2025, is +0.0%.
The Serie's change in percent from it's maximum value, on 09/30/2013, to it's latest available value, on 09/30/2025, is -20.41%.